A trial of assessment of ulcerative colitis treatment with the preparation Nalcrom (disodium cromoglycate)
Korczowski, R.; Nizankowska-Błaz, T.; Romańczuk, W.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy 20(2): 138-140
1988
ISSN/ISBN: 0025-5246 PMID: 3146679 Document Number: 3714
In 10 children aged 8-15 years ulcerative colitis was diagnosed. Treatment was based on Nalcrom (disodium cromoglycate). Remission was achieved in 8 children with evidence of.atopy. The obtained results suggest that Nalcrom should he the drug of choice in the management of patients with allergy-related ulcerative colitis.
Document emailed within 1 workday